@article{2b42f97e1bd44626bf6414e6c4d1c1e6,
title = "Protein therapeutics for cardiovascular disease: It is all about delivery",
keywords = "acute myocardial infarction, drug delivery system, plasminogen activators, thrombolysis, ultrasound",
author = "Tomoko Ichiki and Burnett, {John C.}",
note = "Funding Information: This work was supported by grants from the National Institute of Health ( RO1 HL36634 , PO1 HL76611 , and RO1 HL83231 ) awarded to Dr. Burnett, Jr., and from the American Heart Association with a Scientist Development Grant awarded to Dr. Ichiki ( 12SDG11460017 ) and the Mayo Foundation. Dr. Burnett is the Chair of the Scientific Advisory Board of Nile Therapeutics and a Scientific Advisory to Anexon to which Mayo Clinic has licensed the peptide Cenderitide and ANX042, respectively. ",
year = "2012",
month = dec,
day = "18",
doi = "10.1016/j.jacc.2012.09.026",
language = "English (US)",
volume = "60",
pages = "2558--2560",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "24",
}